Who are Phagenesis's investors?

Phagenesis's investors include Aphelion Capital, Innvotec Ltd., Northern Gritstone, EQT Life Sciences, Sectoral Asset Management.

Phagenesis

8 known investors

Find your way into Phagenesis

Paths you didn't know you had: your email and LinkedIn already hold routes to the Phagenesis team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing. The company serves patients with swallowing disorders caused by neurological conditions, supported by 25 years of clinical research and evidence.

Deep Tech Digital Health Healthtech Medical Devices

Investors · 8

Aphelion Capitallisted by Aphelion Capital

Innvotec Ltd.listed by Innvotec Ltd.London · $317.5K – $635K

Northern Gritstonelisted by Northern GritstoneManchester

How we know: Northern Gritstone's portfolio page · uktech.news · the VCSheet dataset · Not right? Tell us

EQT Life SciencesreportedAmsterdam · $11M – $66M

How we know: funding news · phagenesis.com · Not right? Tell us

Sectoral Asset ManagementreportedMontreal

How we know: funding news · phagenesis.com · Not right? Tell us

Also in the syndicate · 3

AphelionBritish Patient Capital Future FundSectoral

Funding

SEC filings, press & company announcements

Undisclosed amountSeries DSep 2024
Source ↗
Undisclosed amountSeries DMar 2024 · 2 sources
EQT Life Sciences (lead), Sectoral Asset Management (lead), Aphelion, British Patient Capital Future Fund, Northern Gritstone, Sectoral
Source ↗
Undisclosed amountSeries DFeb 2024
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Phagenesis went on to found or lead other companies.

Oern R. StugeChairmanFounded Impulse Dynamics +1 Daniel GreenCEOFounded Precision Microbubbles

In the news

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing - Phagenesisphagenesis.com · Sep 2024

Phagenesis Successfully Closes a $42M Series D Financing Round Led by EQT Life Sciences and Sectoral Asset Management - Phagenesisphagenesis.com · Mar 2024

Frequently asked questions

What does Phagenesis do?: Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing. The company serves patients with swallowing disorders caused by neurological conditions, supported by 25 years of clinical research and evidence.
Who are Phagenesis's investors?: Phagenesis's investors include Aphelion Capital, Innvotec Ltd., Northern Gritstone, EQT Life Sciences, Sectoral Asset Management.